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Abstract
Background: Over the last 30 years the citizens of the United Arab Emirates have experienced major
changes in life-style secondary to increased affluence. Currently, 1 in 5 adults have diabetes mellitus, but
the associations (clustering) among risk factors, as well as the relevance of the concept of the metabolic
syndrome, in this population is unknown.
Aim: To investigate the prevalence and associations among cardiovascular risk factors in this population,
and explore to what extent associations can be explained by the metabolic syndrome according to ATP-
III criteria.
Method:  A community based survey, of conventional risk factors for cardiovascular disease was
conducted among 817 national residents of Al Ain city, UAE. These factors were fasting blood sugar, blood
pressure, lipid profile, BMI, waist circumference, smoking, or CHD family history. Odds ratios between
risks factors, both unadjusted and adjusted for age and sex as well as adjusted for age, sex, and metabolic
syndrome were calculated.
Results: Various risk factors were positively associated in this population; associations that are mostly
unexplained by confounding by age and sex. For example, hypertension and diabetes were still strongly
related (OR 2.5; 95% CI 1.7–3.7) after adjustment. An increased waist circumference showed similar
relationship with hypertension (OR 2.3; 95% CI 1.5–3.5). Diabetes was related to an increased BMI (OR
1.5; 96% CI 1.0–2.3). Smoking was also associated with diabetes (OR 1.9, 95% CI 1.0–3.3).
Further adjustment for metabolic syndrome reduced some associations but several remained.
Conclusion: In this population risk-factors cluster, but associations do not appear to be explained by the
presence/absence of the ATP-III metabolic syndrome. Associations provide valuable information in
planning interventions for screening and management.
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Introduction
The global burden of disease and mortality due to cardio-
vascular diseases is huge, and in this respect the United
Arab Emirates (UAE) is no exception [1]. Much of this
burden is preventable, however, as many of the risk fac-
tors associated with these diseases, such as smoking, dysl-
ipidaemia, hypertension etc. have been identified and are
amenable to targeted pharmacological and/or behav-
ioural interventions. Associations (i.e. correlations in the
presence) and interactions (e.g. the risk associated with
obesity may differ between smokers and non-smokers)
between these risk factors have been reported in different
studies [2-5]. Recognition of such associations and inter-
actions among different risk factors is important in the
prevention and management of cardiovascular disease
and its complications, as well as in providing a better
understanding of the aetiology of these disorders. Any
concentration of high CVD risk factors among an identifi-
able sub-group of the population has obvious implica-
tions for prevention strategies.
Certain combinations of risk factors, often called the
"metabolic syndrome", have been linked to poorer long-
term outcomes. Although, both the existence of this syn-
drome, its precise definition, and its prognostic relevance
have been hotly debated in recent years, it is clear that
combinations of risk factors are associated with poorer
outcomes [6-8] yet the precise nature of these interactions
and associations among risks factors remains moot [9-
11].
While many studies have been carried out to establish
how to reduce and treat cardiovascular risk factors effi-
ciently, both separately and in combination, [12-15] the
majority of these intervention studies were conducted in
the Western world, and have an unclear relevance to those
parts of the world, with different ethnic and genetic back-
grounds and lifestyles, such as the UAE. Lacking region-
ally equivalent studies the UAE has had to adopt or adapt
Western approaches without verification. While several
studies on cardiovascular risk factors have been conducted
in the UAE, [16,17] none have reported how these risk fac-
tors relate and interact.
An important factor that needs to be taken into account in
the UAE is ethnicity. The UAE is currently one of the most
ethnically diverse countries in the world. Eighty percent of
its population consists of non-national (expatriate)
migrant workers (Indians, Pakistanis, other Arabs, Euro-
peans,), and even within Nationals (the subjects of our
study) there exists a great diversity, as the tribal structure
reflects a wide variety of ethnic origins. The importance of
ethnicity and the life-style and environment that comes
with it is apparent from its association with risk factors
such as diabetes. For example, the prevalence of diabetes
in Oman was reported to be 16.1% [18] and in Yemen to
be between 6.5% and 10.4% [19] respectively. Both of
these figures are significantly lower than that found and
reported earlier in this study of the same ethnic groups liv-
ing in a more westernised environment, viz. 23.3% [1].
The effect of immigration into a Western lifestyle has been
reported in other studies. An example being Yemeni Jews
immigrating to Israel who developed high cardiovascular
risk profiles [20].
This study is the first community based epidemiological
study in the UAE to investigate the major risk factor asso-
ciations and how cardiovascular risk factors behave in an
Arab population with a high cardiovascular risk profile.
Methods
A cross-sectional community based study was conducted
involving 817 UAE citizen subjects.
The methodology of sampling and data collection has
been described in detail elsewhere [1]. All continuous risk
factor variables were dichotomized to reflect either "nor-
mal" or recognized high risk values. Specifically, diabetes
was defined as either self-reported diabetes or FBS > = 126
mg/dl, central obesity was defined as waist circumference
> 102(m)/88(f) cm, hypertension as BP > = 140/90 or
being on antihypertensive medication, obesity as BMI > =
30 kg/m2, high TG as > = 150 mg/dl, high LDL > 160 mg/
dl and low HDL as < 40 mg/dl.
Odds ratios and their 95% CIs were used to express the
strength of associations. In addition to unadjusted odds
ratios, odds ratios adjusted for age and sex using the Man-
tel-Haenszel methodology, and those adjusted for age,
sex, and the presence/absence of metabolic syndrome
(ATP-III) are presented. The difference between the two
adjusted odds ratios supposedly reflects the extent to
which the metabolic syndrome "explains" associations
among risk factors.
Results
Table 1 shows associations between key cardiovascular
risk factors, using (Mantel-Haenszel) odds ratios (OR),
viz. BMI, waist circumference, hypertriglycidaemia, low
HDL, high LDL, Diabetes, hypertension, smoking, and
family history of coronary heart disease in a first degree
relative. Associations between risk factors were then
adjusted for age and sex to remove the effect of obvious
confounders (Table 2). After adjusting for age and sex,
hypertension and diabetes remain strongly related with
an OR of 2.5 (95% CI: 1.7–3.7; p < 0.00001). Obesity and
hypertension showed a similar relationship with an OR of
2.3 (95% CI: 1.5–3.5; p < 0.001) with increased waist cir-
cumference. About 50% of the hypertensive patients are
obese with the prevalence of hypertension increasing withCardiovascular Diabetology 2009, 8:21 http://www.cardiab.com/content/8/1/21
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Table 1: The raw associations of the different risk factors studied
Diabetes 4.1
2.8–5.8
Central Obesity 2.2 1.3
1.5–3.2 0.9–1.8
Obesity 2 1.1 15.9
1.4–2.8 0.8–1.6 10.5–23.8
Smoking 1 1.3 0.8 0.8
0.5–1.7 0.8–2.1 0.5–1.2 0.5–1.3
High TG* 1.7 1.6 1.4 1.1 1.2
1.2–2.4 1.2–2.3 1.0–1.9 0.8–1.5 0.8–2.0
High LDL 1 0.6 0.9 1.2 1 1
0.6–1.5 0.4–1.0 0.6–1.4 0.9–1.8 0.5–1.7 0.7–1.4
Low HDL 1.6 1.5 0.9 1.1 2.6 1.6 1.2
1.1–2.2 1.1–2.1 0.7–1.3 0.8–1.1 1.6–4.2 1.2–2.2 0.9–1.7
Family history of CHD 0.8 0.7 1.3 1.8 2.4 1 1.4 1.2
0.5–1.4 0.4–1.2 0.8–2.0 1.1–2.7 1.4–4.3 0.6–1.6 0.8–2.3 0.8–1.8
Hypertension Diabetes Central Obesity Obesity Smoking High TG High LDL Low HDL
Table 2: Odds ratios of the associations among different cardiovascular risk factors adjusted for age and sex, using Mantel-Haenszel's 
method
Diabetes 2.5
1.7–3.7
Central Obesity 2.3 1.2
1.5–3.5 0.8–1.7
Obesity 2.5 1.5 15.2
1.6–3.6 1.0–2.3 9.7–23.8
Smoking 1.5 1.8 1.2 1.1
0.8–3.0 1.0–3.3 0.7–2.1 0.7–1.9
High TG 1.6 1.5 1.5 1.1 1.2
1.1–2.3 1.1–2.2 1.0–2.1 0.8–1.5 0.7–1.9
High LDL 0.8 0.5 1 1.4 0.9 1
0.5–1.3 0.3–0.8 0.6–1.5 0.9–2.0 0.5–1.6 0.7–1.5
Low HDL 1.6 1.4 1.1 1.3 1.8 1.5 1.1
1.1–2.4 1.0–2.0 0.8–1.5 0.9–1.8 1.1–3.1 1.1–2.0 0.8–1.6
Family history of CHD 0.9 0.9 1.2 1.6 3 1 1.5 1.3
0.5–1.7 0.5–1.6 0.8–1.9 1.0–2.5 1.5–6.0 0.7–1.6 0.9–2.5 0.8–2.0
Hypertension Diabetes Central Obesity Obesity Smoking High TG High LDL Low HDLCardiovascular Diabetology 2009, 8:21 http://www.cardiab.com/content/8/1/21
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increasing BMI from 15% in those with BMI less than 25
Kg/m2 to 40% in those with BMI equal or more than 40
Kg/m2.
Similarly, an increasing BMI was associated with diabetes
with the OR for the association between diabetes and
obesity (BMI > = 30) being 1.5 (95% CI : 1.0–2.3), but the
association with diabetes was somewhat weaker and not
statistically significant for increased waist circumference
(as opposed to BMI), with an OR of 1.2 (95% CI : 0.8–
1.7). Figure 1 shows the relationship between an increas-
ing BMI and waist circumference on one hand, with dia-
betes and hypertension on the other.
Dyslipidaemia was differently related to hypertension and
diabetes. A significant association was found between
hypertension and increased TG and decreased HDL, with
ORs of 1.6 (95% CI: 1.1–2.3; p = 0.02) and 1.6 (95% CI:
1.1–2.4, p = 0.01) respectively.
Associations for diabetes demonstrated a weak, but statis-
tically significant, association with increasing TG [OR of
1.5 (95% CI: 1.1–2.2)], an interesting, inverse relation-
ship, was seen with LDL with an OR of 0.5(95% CI: 0.3–
0.8; p = 0.001) i.e. diabetes was found to be associated
with low LDL.
In the case of dyslipidaemia and measures of obesity the
only association was between increased waist circumfer-
ence and high TG, with an OR of 1.5 (95% CI: 1.0–2.1).
There was no association between waist circumference
and high LDL or low HDL, nor did dyslipidaemia param-
eters show any significant associations with an increased
BMI.
Smoking showed an interesting strong relationship with a
history of premature IHD in first degree relative OR 3
(95% CI: 1.5–6; p = 0.001). A weak association was
noticed as well between high BMI and a history of prema-
ture IHD in a first degree relative OR 1.6 (1–2.5) but it did
not reach statistical significance (p = 0.4).
Another interesting finding was that diabetes and smok-
ing are significantly related, with an OR of 1.8 (95% CI:
1.0–3.3).
Table 3 represents associations after adjusting for the met-
abolic syndrome. Although many associations were
reduced there remained a significant association between
Waist circumference and BMI related to diabetes, hypertension and those with both diabetes and hypertension Figure 1
Waist circumference and BMI related to diabetes, hypertension and those with both diabetes and hyperten-
sion.
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obesity and high LDL with an OR of 1.7 (95% CI: 1.1–
2.5).
Blood pressure was related to gender (Figure 2), with
females having lower systolic and diastolic blood pressure
than males, the difference decreasing with age.
Figure 3 shows the change in prevalence with age and sex
of the metabolic syndrome (using ATP III criteria [21]). It
reaches a prevalence of 37% in males around 50 years old
and exceeds 50% in females between 45 and 50 years.
Overall prevalence was 37.6% more than that reported in
our previous report (22.7%) [1] since in the former per-
centage diabetics and self-reported (treated) hypertensives
were included as having IGT and high blood pressure
respectively.
Ethnicity and its relationship to risk factors was studied by
inquiring about subjects' tribe name, place of birth and
their self-identified origins. Analysis by tribes was compli-
cated by the large number of tribes giving rise to small
sample sizes per group. Subjects were therefore grouped
to (a) originally from UAE and born in the UAE, (b) orig-
inally from Yemen, (c) originally from Oman, and (d)
other origins. There appeared to be no striking associa-
tions between ethnicity and prevalence of risk factors,
with the exception that subjects originally from Yemen
tended to have a somewhat higher BMI, with an OR for
obesity of 0.6 (95% CI 0.4–0.9).
Discussion
The study revealed some important associations among
CVD risk factors, which persisted after correcting for the
confounders of age and gender. Adjusting for the meta-
bolic would be expected to nullify most of these associa-
tions as the syndrome is defined in terms of the same risk
factors. Despite this several associations persisted after
that adjustment such as those between hypertension and
obesity and between high LDL and obesity. The implica-
tions of these findings is that the premise of a simple uni-
dimensional (metabolic) syndrome, at least not as
defined by the ATP III criteria, cannot be applied to the
population studied.
The population of Al Ain, as in many parts of the world
and like other Arabian Gulf states, has experienced a
major shift in lifestyle that has been accompanied by a
proliferation of cardiovascular risk factors [1]. In this Arab
population the prevalence and association among differ-
ent risk factor interactions is worth reporting as it provides
Table 3: Odds ratios of the associations among different cardiovascular risk factors adjusted for Age, sex and ATP defined metabolic 
syndrome
Diabetes 1.5
0.9–2.2
Central Obesity 1.2 0.4
0.7–2.0 0.2–0.7
Obesity 1.9 0.9 16.1
1.2–3.0 0.6–1.4 9.5–27.3
Smoking 1.4 1.5 0.9 0.8
0.7–2.9 0.8–2.8 0.5–1.7 0.5–1.5
High TG 0.7 0.6 0.4 0.6 10.9
0.5–1.1 0.4–0.9 0.2–0.7 0.4–0.8 0.5–1.7
High LDL 1 0.5 1.3 1.7 0.9 1.4
0.6–1.6 0.3–0.9 0.8–2.0 1.1–2.5 0.5–1.6 0.9–2.2
Low HDL 1.1 0.7 0.4 1 1.6 0.7 1.3
0.7–1.6 0.4–1.0 0.3–0.7 0.7–1.3 0.9–2.8 0.5–1.1 0.9–2.0
Family history of CHD 0.9 0.8 0.9 1.5 2.7 0.9 1.6 1.1
0.5–1.6 0.4–1.5 0.5–1.5 0.9–2.3 1.3–5.5 0.5–1.6 0.9–2.7 0.7–1.9
Hypertension Diabetes Central Obesity Obesity Smoking High TG High LDL Low HDLCardiovascular Diabetology 2009, 8:21 http://www.cardiab.com/content/8/1/21
Page 6 of 9
(page number not for citation purposes)
The Gender influence on blood pressure and the change of blood pressure with age Figure 2
The Gender influence on blood pressure and the change of blood pressure with age.
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information for patients and health care policy makers to
prevent and manage the problem with targeted interven-
tions.
A recent meta-analysis to determine the best index of
obesity examined the association between diabetes and
the three indices of body mass index, waist circumference,
and waist/hip ratio. The findings were inconclusive to
determine the usefulness of waist circumference or waist/
hip ratio over body mass index [22]. In this study hyper-
tension was correlated with both increasing BMI and
increasing waist circumference while diabetes correlated
predominantly with increased BMI. In a study done on
Asians, Waist-to-Stature Ratio was a stronger correlate
than BMI of diabetes, but these two indicators of obesity
were equally strongly associated with hypertension [23]. A
meta-analysis has supported this finding in the case of
hypertension [24].
Our finding of dyslipidaemia (increased triglycerides and
low HDL) being associated with diabetes has been shown
in other studies [25] but in this study diabetes was para-
doxically associated with low LDL. This could be due to
lipid lowering medication or the effect of lifestyle
changes. This paradoxical association was not true for
hypertension nor for diabetes and hypertension com-
bined in the same individual.
There is a strong association between smoking and family
history of premature CHD and between increased BMI
and family history of premature CHD. This could be
explained by a genetic predisposition to develop risk fac-
tors for cardiovascular diseases but may equally be due to
clustering of adverse lifestyle choices within families. This
needs to be explored in greater detail. Interestingly, our
study corroborates the association between diabetes and
smoking that was reported in a number of studies, indicat-
ing that cigarette smoking is an independent and -of
course- modifiable determinant of type 2 diabetes melli-
tus. Regrettably, we did not measure passive smoking, so
we could not confirm the association of DM with passive
The prevalence of Metabolic Syndrome Figure 3
The prevalence of Metabolic Syndrome.Cardiovascular Diabetology 2009, 8:21 http://www.cardiab.com/content/8/1/21
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exposure to cigarette smoke that has also been reported
[26-28].
Blood pressure showed about 10 mmHg differences
between males and females in the younger age group,
being higher in males, but this difference diminished with
age. In the age group above 60 years it diverts again but no
firm conclusions can be reached in view of the small sam-
ple sizes in the older age groups. Our findings largely
coincide with a study conducted in Japan [29].
Many studies have identified the association of diabetes
and hypertension, including one conducted in nearby
Saudi Arabia [30]. As both are influenced by obesity our
findings of a similar association is to be expected. The pre-
cise causal pathway among these variables cannot be
established in our cross-sectional study.
Metabolic syndrome allegedly describes a cluster of cardi-
ovascular risk factors. This study failed to find a clear asso-
ciation between the different metabolic syndrome criteria
in the individuals diagnosed with the syndrome. This cor-
responds with other recent reports that have used factor
analysis to investigate these associations [28-30]. This
would suggest that the causal link between these diagnos-
tic components may not be sufficiently strong to justify
the concept of a "syndrome". However, statistical criteria
should not have the last word and it may be necessary to
study other pathological changes reported in relation to
the metabolic syndrome to investigate if a unique syn-
drome exists. In addition, the suggested prognostic value
of this syndrome was found to be variable depending on
the specific definition used [31]. This clearly indicates that
it needs to be further explored in order to determine
whether its prognostic value exceeds that of the (multipli-
cative) Framingham risk score which simply treats CVD
risk empirically without any reference to nosological con-
cepts or hypotheses.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LMB, ADR, TMJ, NMA, MKN, FAN, MFA participated in
the study design. NMA, MKN, FAN, MFA, SA carried out
the study in the centres. LMB and AOO coordinated the
study. NJDN performed the statistical analysis. LMB, ADR,
NJDN drafted the manuscript. All authors read and
approved the final manuscript.
References
1. Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO,
Ahmed NM, Naziruldeen MK, Al-Sayed MF, Nour FA: High preva-
lence of the cardiovascular risk factors in Al-Ain, United
Arab Emirates. An emerging health care priority.  Saudi Med
J 2008, 29(8):1173-1178.
2. Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard
BV:  A longitudinal study of hypertension risk factors and
their relation to cardiovascular disease: the Strong Heart
Study.  Hypertension 2006, 47(3):403-409.
3. Tohme RA, Jurjus AR, Estephan A: The prevalence of hyperten-
sion and its association with other cardiovascular disease risk
factors in a representative sample of the Lebanese popula-
tion.  J Hum Hypertens 2005, 19(11):861-868.
4. Shapo L, Pomerleau J, McKee M: Epidemiology of hypertension
and associated cardiovascular risk factors in a country in
transition: a population based survey in Tirana City, Albania.
J Epidemiol Community Health 2003, 57(9):734-739.
5. Borde-Perry WC, Campbell KL, Murtaugh KH, Gidding S, Falkner B:
The association between hypertension and other cardiovas-
cular risk factors in young adult African Americans.  J Clin
Hypertens (Greenwich) 2002, 4(1):17-22.
6. Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S: Association
between metabolic syndrome and risk of stroke: a meta-
analysis of cohort studies.  Cerebrovasc Dis 2008, 25(6):539-547.
7. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Mon-
tori VM: Metabolic syndrome and risk of incident cardiovas-
cular events and death: a systematic review and meta-
analysis of longitudinal studies.  J Am Coll Cardiol 2007,
49(4):403-414.
8. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of car-
diovascular disease: a meta-analysis.  Am J Med 2006,
119(10):812-819.
9. Reaven GM: The metabolic syndrome: is this diagnosis neces-
sary?  Am J Clin Nutr 2006, 83(6):1237-1247.
10. Yarnell JW, Patterson CC, Bainton D, Sweetnam PM: Is metabolic
syndrome a discrete entity in the general population? Evi-
dence from the Caerphilly and Speedwell population studies.
Heart 1998, 79(3):248-252.
11. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome:
time for a critical appraisal: joint statement from the Amer-
ican Diabetes Association and the European Association for
the Study of Diabetes.  Diabetes Care 2005, 28(9):2289-2304.
12. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG:
Translating the Diabetes Prevention Program into the com-
munity. The DEPLOY Pilot Study.  Am J Prev Med 2008,
35(4):357-363.
13. Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA: Translat-
ing the Diabetes Prevention Program into an urban medi-
cally underserved community: a nonrandomized
prospective intervention study.  Diabetes Care 2008,
31(4):684-689.
14. Ackermann RT, Marrero DG: Adapting the Diabetes Prevention
Program lifestyle intervention for delivery in the commu-
nity: the YMCA model.  Diabetes Educ 2007, 33(1):69. 74-69, 78.
15. Ratner RE: An update on the Diabetes Prevention Program.
Endocr Pract 2006, 12(Suppl 1):20-24.
16. Al-Kaabi J, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N:
Assessment of dietary practice among diabetic patients in
the United arab emirates.  Rev Diabet Stud 2008, 5(2):110-115.
17. Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed
R, Lukic M, Nicholls MG, Kazam E, Algawi K, Al-Kaabi J, Leduc C,
Sabri S, El-Sadig M, Elkhumaidi S, Agarwal M, Benedict S: Prevalence
of diabetes mellitus and its complications in a population-
based sample in Al Ain, United Arab Emirates.  Diabetes Res
Clin Pract 2007, 78(3):369-377.
18. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P: Increasing
prevalence of diabetes mellitus in Oman.  Diabet Med 2002,
19(11):954-957.
19. Gunaid AA: Prevalence of known diabetes and hypertension in
the Republic of Yemen.  East Mediterr Health J 2002, 8(2–
3):374-385.
20. Weingarten MA, Katzir I, Sprecher E, Kobzantsev S, Zelzer C, Kahan
E:  Diabetes and ischemic heart disease among Yemenite
immigrants in Israel.  Isr Med Assoc J 2000, 2(3):207-210.
21. The Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults: Executive Summary of the Third
Report of the National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation, and Treat-
ment of High Blood Cholesterol in Adults (Adult Treatment
Panel III).  2008.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cardiovascular Diabetology 2009, 8:21 http://www.cardiab.com/content/8/1/21
Page 9 of 9
(page number not for citation purposes)
22. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K: Comparison of
body mass index, waist circumference, and waist/hip ratio in
predicting incident diabetes: a meta-analysis.  Epidemiol Rev
2007, 29:115-128.
23. Nyamdorj R, Qiao Q, Lam TH, et al.: BMI compared with central
obesity indicators in relation to diabetes and hypertension in
Asians.  Obesity (Silver Spring) 2008, 16(7):1622-1635.
24. Is central obesity a better discriminator of the risk of hyper-
tension than body mass index in ethnically diverse popula-
tions?  J Hypertens 2008, 26(2):169-177.
25. Ghoddusi K, Ameli J, Kachuee H, Pourfarziani V, Saadat A, Karami Q:
Association of diabetes mellitus and dyslipidaemias in the
Tehran population.  East Mediterr Health J 2008, 14(3):647-653.
26. Radzeviciene L, Ostrauskas R: [Smoking and type 2 diabetes
mellitus].  Medicina (Kaunas) 2006, 42(7):559-565.
27. Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospec-
tive study of cigarette smoking and the incidence of diabetes
mellitus among US male physicians.  Am J Med 2000,
109(7):538-542.
28. Hayashino Y, Fukuhara S, Okamura T, Yamato H, Tanaka H, Tanaka
T ,  K a d o w a k i  T ,  U e s h i m a  H :  A prospective study of passive
smoking and risk of diabetes in a cohort of workers: the
High-Risk and Population Strategy for Occupational Health
Promotion (HIPOP-OHP) study.  Diabetes Care 2008,
31(4):732-734.
29. Suzuki Y, Kuwajima I, Kuramoto K, Otsuka K: [Age and gender dif-
ference in circadian rhythm in blood pressure].  Nippon Ronen
Igakkai Zasshi 1993, 30(9):778-786.
30. El-Hazmi MA, Warsy AS: Association of hypertension and non-
insulin-dependent diabetes mellitus in the Saudi population.
Ann Saudi Med 2001, 21(1–2):5-8.
31. Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L: All-cause
and cardiovascular mortality using the different definitions
of metabolic syndrome.  Am J Cardiol 2008, 102(2):188-191.